Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Mar 15, 2017; 9(3): 105-120
Published online Mar 15, 2017. doi: 10.4251/wjgo.v9.i3.105
Published online Mar 15, 2017. doi: 10.4251/wjgo.v9.i3.105
Gene | Count CIMP+ | % CIMP+ | Count CIMP- | % CIMP- | P% Diff | P-value | FDR | Pathway |
KMT2D | 35 | 20.30% | 10 | 4.30% | 16.00% | 6.22E-07 | 2.24E-05 | Chromatin |
ARID1A | 60 | 34.90% | 32 | 13.90% | 21.00% | 1.15E-06 | 2.24E-05 | Chromatin |
RNF43 | 42 | 24.40% | 17 | 7.40% | 17.10% | 3.04E-06 | 3.79E-05 | Wnt |
CSF3R | 19 | 11.00% | 2 | 0.90% | 10.20% | 4.19E-06 | 3.79E-05 | ERK |
SOX7 | 14 | 8.10% | 0 | 0.00% | 8.10% | 4.86E-06 | 3.79E-05 | ERK |
PIK3CA | 48 | 27.90% | 26 | 11.30% | 16.70% | 2.62E-05 | 1.70E-04 | PI3K/RAS |
PAX6 | 17 | 9.90% | 2 | 0.90% | 9.00% | 3.96E-05 | 2.21E-04 | Differentiation |
ATM | 37 | 21.50% | 17 | 7.40% | 14.20% | 5.05E-05 | 2.46E-04 | DNA damage |
KRAS | 52 | 30.20% | 32 | 13.90% | 16.40% | 1.04E-04 | 4.53E-04 | PI3K/RAS |
EGR1 | 15 | 8.70% | 2 | 0.90% | 7.90% | 1.63E-04 | 6.37E-04 | Differentiation |
GATA3 | 19 | 11.00% | 5 | 2.20% | 8.90% | 2.22E-04 | 7.87E-04 | NF-KB |
KMT2C | 38 | 22.10% | 22 | 9.50% | 12.60% | 6.15E-04 | 2.00E-03 | Chromatin |
ALDH2 | 10 | 5.80% | 1 | 0.40% | 5.40% | 1.18E-03 | 3.30E-03 | Metabolic |
CDK12 | 18 | 10.50% | 6 | 2.60% | 7.90% | 1.18E-03 | 3.30E-03 | PI3K/RAS |
SAFB | 15 | 8.70% | 4 | 1.70% | 7.00% | 1.44E-03 | 3.73E-03 | Chromatin |
BCOR | 19 | 11.00% | 7 | 3.00% | 8.00% | 1.68E-03 | 4.09E-03 | Chromatin |
PTEN | 24 | 14.00% | 11 | 4.80% | 9.20% | 1.97E-03 | 4.32E-03 | PI3K/RAS |
AXIN2 | 21 | 12.20% | 9 | 3.90% | 8.30% | 2.00E-03 | 4.32E-03 | Wnt |
CTCF | 14 | 8.10% | 4 | 1.70% | 6.40% | 2.73E-03 | 5.41E-03 | Chromatin |
PALB2 | 11 | 6.40% | 2 | 0.90% | 5.50% | 2.77E-03 | 5.41E-03 | DNA repair |
ERBB3 | 18 | 10.50% | 7 | 3.00% | 7.40% | 2.96E-03 | 5.49E-03 | PI3K/RAS |
ERBB4 | 29 | 16.90% | 17 | 7.40% | 9.50% | 4.05E-03 | 6.97E-03 | PI3K/RAS |
FBXW7 | 32 | 18.60% | 20 | 8.70% | 9.90% | 4.11E-03 | 6.97E-03 | Notch |
CIC | 23 | 13.40% | 12 | 5.20% | 8.20% | 6.55E-03 | 1.06E-02 | Proliferation |
HLA.A | 17 | 9.90% | 8 | 3.50% | 6.40% | 1.13E-02 | 1.71E-02 | Immune |
MSH6 | 19 | 11.00% | 10 | 4.30% | 6.70% | 1.14E-02 | 1.71E-02 | MMR |
ERBB2 | 15 | 8.70% | 8 | 3.50% | 5.30% | 2.98E-02 | 4.21E-02 | PI3K/RAS |
CASP8 | 13 | 7.60% | 6 | 2.60% | 5.00% | 3.02E-02 | 4.21E-02 | Apoptosis |
SMAD4 | 27 | 15.70% | 20 | 8.70% | 7.00% | 4.05E-02 | 5.45E-02 | Wnt |
TFE3 | 6 | 3.50% | 1 | 0.40% | 3.10% | 4.53E-02 | 5.90E-02 | Wnt |
APC | 82 | 47.70% | 87 | 37.70% | 10.00% | 5.24E-02 | 6.60E-02 | Wnt |
NRAS | 10 | 5.80% | 5 | 2.20% | 3.60% | 6.55E-02 | 7.74E-02 | PI3K/RAS |
SMARCB1 | 10 | 5.80% | 5 | 2.20% | 3.60% | 6.55E-02 | 7.74E-02 | Chromatin |
IGFBP7 | 3 | 1.70% | 0 | 0.00% | 1.70% | 7.70E-02 | 8.65E-02 | DNA Damage |
TBL1XR1 | 6 | 3.50% | 2 | 0.90% | 2.60% | 7.76E-02 | 8.65E-02 | Wnt |
- Citation: Sánchez-Vega F, Gotea V, Chen YC, Elnitski L. CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies. World J Gastrointest Oncol 2017; 9(3): 105-120
- URL: https://www.wjgnet.com/1948-5204/full/v9/i3/105.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i3.105